These 7 prognostic features are GNB3, which has been shown to affect OS in pancreatic cancer (22); GNG7, which can be used as a therapeutic target in pancreatic cancer (23); IQGAP1, the overexpression of which promotes pancreatic cancer progression (24), and 4 other genes (ACACB GNA15, STXBP1, VAMP2) that have not yet been reported in pancreatic cancer. This evidence concerns the gene STXBP1 and familial pancreatic carcinoma.